Gelatin (Pharma): Market Size & Forecast 2026

The global pharmaceutical gelatin market sits at approximately USD 2.1 billion in 2025 (base year), held in a structurally tight balance between concentrated bovine-hide feedstock supply, accelerating capsule demand from generics and nutraceutical manufacturers, and a December 2025 US anti-dumping determination that re-rates the competitive map for hard empty capsules. A 5.2 percent CAGR through 2032 carries the market to roughly USD 3.0 billion, with the growth vector sitting primarily in softgel and high-functionality tablet-binder applications. > **Analyst Take.** The anti-dumping duties on hard empty capsules are the single most consequential 2026 inflection, but buyers are misreading the direction. The duties protect US capsule manufacturers, which pulls volume away from Asian gelatin suppliers and tightens availability for buyers who source gelatin directly. The right sequence is:

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.